Trials / Withdrawn
WithdrawnNCT04360135
Preemptive Acetaminophen for Postoperative Pain Control Following Minimally Invasive Hysterectomy
Preemptive Acetaminophen for Postoperative Pain Control Following Minimally Invasive Hysterectomy: a Randomized Control Trial
- Status
- Withdrawn
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Montefiore Medical Center · Academic / Other
- Sex
- Female
- Age
- 18 Years – 100 Years
- Healthy volunteers
- Accepted
Summary
This study is investigating whether administration of acetaminophen the day before surgery improves post operative pain following minimally invasive hysterectomy. Patients will receive either acetaminophen or placebo to take twice per day the day prior to their scheduled surgery. The morning of surgery all participants will receive oral acetaminophen at least 30 minutes prior to surgery. The investigators will examine whether there is a difference in post operative pain between the two groups.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Acetaminophen | Preemptive acetaminophen the day before surgery |
| DRUG | Placebo | Preemptive placebo the day before surgery |
Timeline
- Start date
- 2020-05-06
- Primary completion
- 2021-03-08
- Completion
- 2021-03-08
- First posted
- 2020-04-24
- Last updated
- 2022-08-18
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04360135. Inclusion in this directory is not an endorsement.